PW-PREMIERE-LOG-small

August 19, 2020

12:00p - 3:00p (EDT)
Registration for Subscribers is FREE*
Registration Fee for Non-Subscribers is $99

Program Information

neuro imaging

While pain management education is needed more than ever, for the safety of faculty and attendees, we have postponed our live PAINWeekEnd Regional Conferences until 2021. Meanwhile, we are pleased to announce that we are launching a new educational webinar series, PAINWeek Premiere, which will provide 3.0 CE/CME credit hours. Beginning on September 16, they will be presented twice per week—on alternating Wednesdays and Saturdays (except preceding/following holidays).

  • If you have not registered for PWLVC, or registered for only the live virtual portion, you can register for this August 19th activity for $99. However, it’s not too late to either subscribe or upgrade your current PWLVC package to receive the added value of additional CE/CME activities for FREE. Contact us at (973) 415-5100 for information on how to upgrade.
  • Subscribers have access to 120 CE/CME credit hours PLUS additional PAINWeek Premiere activities presented throughout the year.
*If you have already registered for the PAINWeek 2020 Live Virtual Enduring Conference (PWLVC) and on demand subscription, PAINWeek Premiere is FREE. Contact us at (973) 415-5100 to register for the August 19th activity.

The Speakers

Jennifer Bolen
Jennifer Bolen
JD
Mark Garofoli
Mark Garofoli
PharmD, MBA, BCGP, CPE
Douglas L. Gourlay
Douglas L. Gourlay
MD, MSc, FRCPC, DFASAM

Agenda

12:00p
-
1:00p
Mirror Mirror on the Wall: Who's the FDA's Fairest ADF of All?
Faculty Mark Garofoli

Challenge accepted. Our country has made numerous strides in advancing patient care, and more particularly conducting efforts to ensure that lives within the national opioid crisis are saved and/or improved. One of those positive strides involves the FDA approval of abuse deterrent formulation (ADF) opioid medications, with the aim of preventing the transition from the misuse and/or abuse of prescription opioid medications to illicit (and possibly laced) diacetylmorphine (aka heroin). How do these formulations work, one might ask? Which ADF opioid medications are not only available on the us market, but also specifically approved as an ADF opioid medication? Are these ADFs really foolproof? Well, the street chemists of our country have already accepted the challenge to be knowledgeable on all of the above. Now it’s our turn as healthcare professionals to get up to speed on these risk reduction entities.

UAN 0530-0000-20-042-L04-P
Rx hours 0.8
1:00p
-
1:45p
After the Goldrush: Testing Medical Cannabis and CBD in Chronic Pain Patients
Faculty Douglas L. Gourlay

The emergence of various cannabis products has complicated the management of chronic pain, in part due to the conflicting legal status of this group of drugs at the federal vs many state levels. Recent amendments to federal law in the form of the Hemp Farming Act 2018 by legalizing cannabidiol (CBD) derived from the hemp plant has led to an explosion of CBD containing products in the US market. Unfortunately, not all CBD products available for purchase actually are pure CBD. This session will explore the challenges associated with the application and interpretation of current urine drug testing methods.

UAN 0530-0000-20-025-L01-P
Rx hours 0.0
1:45p
-
2:45p
Drugs, Documentation, and DEA: Improving Your Charting of Prescribing Rationale in 2020 and Beyond
Faculty Jennifer Bolen

Overlooking the importance of carefully documenting the rationale for the use of a controlled medication can land a prescriber in hot water with their licensing board or the DEA. This course will focus on what it takes to move beyond the problems associated with both EMR and handwritten medical charts, and into the documentation of cogent notes signaling proper patient evaluation, including risk evaluation, rationale for the use of controlled medication, and ongoing encounters with the patient.

UAN 0530-0000-20-027-L03-P
Rx hours 0.0
2:45p
-
3:00p
Faculty Q&A

Program Guide

Click here to download the program guide for this webinar.

CE/CME and Accreditation

This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere--and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeekEnd Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering a full day of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 3.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

  • Discuss common methods of manipulation of abuse-deterrent formulation opioid medications
  • Discuss drug testing methods in the context of state vs federal law
  • Review DEA regulatory requirements for a valid controlled substance prescription during the COVID-19 public health emergency and using telemedicine

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

* This CE/CME activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 3.0 contact hour(s) (which includes 0.80 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 3.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 3 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 3.0 contact hours (0.3 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend the courses. Web link to credit application and evaluation form will be emailed to participants the following week. Once completed, participants will be able to immediately download/print their certificates. Pharmacy learners will have their credits uploaded directly to NABP within 60 days of completion.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Andrea Funk—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Liddy Knight—Nothing to disclose